U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Refractory Angioimmunoblastic T-Cell Lymphoma

MedGen UID:
163154
•Concept ID:
C0854834
•
Neoplastic Process
Synonym: Angioimmunoblastic T-Cell Lymphoma Refractory

Definition

Angioimmunoblastic T-cell lymphoma resistant to treatment. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRefractory Angioimmunoblastic T-Cell Lymphoma

Professional guidelines

PubMed

Cyclosporine, prednisone, and high-dose immunoglobulin treatment of angioimmunoblastic T-cell lymphoma refractory to prior CHOP or CHOP-like regimen.
Chen XG, Huang H, Tian Y, Guo CC, Liang CY, Gong YL, Zou BY, Cai RQ, Lin TY
Chin J Cancer 2011 Oct;30(10):731-8. doi: 10.5732/cjc.011.10071. PMID: 21959050Free PMC Article

Recent clinical studies

Etiology

Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up.
Fabbri A, Cencini E, Pietrini A, Gozzetti A, Defina M, Fontanelli G, Mazzei MA, Volterrani L, Bocchia M
Hematol Oncol 2013 Dec;31(4):213-7. Epub 2012 Nov 14 doi: 10.1002/hon.2038. PMID: 23161606

Diagnosis

Anti-CCR4 Monoclonal Antibody Mogamulizumab Followed by the GDP (Gemcitabine, Dexamethasone and Cisplatin) Regimen in Primary Refractory Angioimmunoblastic T-Cell Lymphoma.
Kato H, Yamamoto K, Higuchi Y, Yamamoto H, Saito T, Taji H, Yatabe Y, Nakamura S, Kinoshita T
Chemotherapy 2017;62(1):19-22. Epub 2016 May 27 doi: 10.1159/000444518. PMID: 27226129
Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
Broccoli A, Pellegrini C, Celli M, Argnani L, Agostinelli C, Pileri S, Zinzani PL
Clin Lymphoma Myeloma Leuk 2014 Aug;14(4):e119-22. Epub 2014 Feb 4 doi: 10.1016/j.clml.2014.01.011. PMID: 24629851
Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up.
Fabbri A, Cencini E, Pietrini A, Gozzetti A, Defina M, Fontanelli G, Mazzei MA, Volterrani L, Bocchia M
Hematol Oncol 2013 Dec;31(4):213-7. Epub 2012 Nov 14 doi: 10.1002/hon.2038. PMID: 23161606

Therapy

Therapeutic effect of chidamide on relapsed refractory angioimmunoblastic T-cell lymphoma: A case report and literature review.
Jin J, Zheng C, Wu S
Medicine (Baltimore) 2018 Jan;97(2):e9611. doi: 10.1097/MD.0000000000009611. PMID: 29480865Free PMC Article
Anti-CCR4 Monoclonal Antibody Mogamulizumab Followed by the GDP (Gemcitabine, Dexamethasone and Cisplatin) Regimen in Primary Refractory Angioimmunoblastic T-Cell Lymphoma.
Kato H, Yamamoto K, Higuchi Y, Yamamoto H, Saito T, Taji H, Yatabe Y, Nakamura S, Kinoshita T
Chemotherapy 2017;62(1):19-22. Epub 2016 May 27 doi: 10.1159/000444518. PMID: 27226129
Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomide.
Beckers MM, Huls G
Eur J Haematol 2013 Feb;90(2):162-3. Epub 2013 Jan 7 doi: 10.1111/ejh.12053. PMID: 23227803
Successful treatment of chemotherapy-refractory angioimmunoblastic T cell lymphoma with cyclosporin A.
Kobayashi T, Kuroda J, Uchiyama H, Matsumoto Y, Horiike S, Taniwaki M
Acta Haematol 2012;127(1):10-5. Epub 2011 Oct 7 doi: 10.1159/000330950. PMID: 21986307
Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone.
Ramasamy K, Lim Z, Pagliuca A, Salisbury JR, Mufti GJ, Devereux S
Haematologica 2006 Aug;91(8 Suppl):ECR44. PMID: 16923528

Prognosis

Therapeutic effect of chidamide on relapsed refractory angioimmunoblastic T-cell lymphoma: A case report and literature review.
Jin J, Zheng C, Wu S
Medicine (Baltimore) 2018 Jan;97(2):e9611. doi: 10.1097/MD.0000000000009611. PMID: 29480865Free PMC Article
Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomide.
Beckers MM, Huls G
Eur J Haematol 2013 Feb;90(2):162-3. Epub 2013 Jan 7 doi: 10.1111/ejh.12053. PMID: 23227803
Impressive activity of lenalidomide monotherapy in refractory angioimmunoblastic T-cell lymphoma: report of a case with long-term follow-up.
Fabbri A, Cencini E, Pietrini A, Gozzetti A, Defina M, Fontanelli G, Mazzei MA, Volterrani L, Bocchia M
Hematol Oncol 2013 Dec;31(4):213-7. Epub 2012 Nov 14 doi: 10.1002/hon.2038. PMID: 23161606
Successful treatment of chemotherapy-refractory angioimmunoblastic T cell lymphoma with cyclosporin A.
Kobayashi T, Kuroda J, Uchiyama H, Matsumoto Y, Horiike S, Taniwaki M
Acta Haematol 2012;127(1):10-5. Epub 2011 Oct 7 doi: 10.1159/000330950. PMID: 21986307
Successful treatment of refractory angioimmunoblastic T-cell lymphoma with thalidomide and dexamethasone.
Ramasamy K, Lim Z, Pagliuca A, Salisbury JR, Mufti GJ, Devereux S
Haematologica 2006 Aug;91(8 Suppl):ECR44. PMID: 16923528

Clinical prediction guides

Anti-CCR4 Monoclonal Antibody Mogamulizumab Followed by the GDP (Gemcitabine, Dexamethasone and Cisplatin) Regimen in Primary Refractory Angioimmunoblastic T-Cell Lymphoma.
Kato H, Yamamoto K, Higuchi Y, Yamamoto H, Saito T, Taji H, Yatabe Y, Nakamura S, Kinoshita T
Chemotherapy 2017;62(1):19-22. Epub 2016 May 27 doi: 10.1159/000444518. PMID: 27226129

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...